10-K Filing

IDEXX LABORATORIES INC /DE CIK: 874716 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0000874716-16-000020`
Period End Date	20151231
Filing Date	20160217
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	c716-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 115 Cash Flow Statement 99 Stockholders Equity 29 Comprehensive Income 40

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.31M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$5.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$223.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.24M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	101.95M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$213.59M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	240,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $5,128 in 2015 and $4,306 in 2014	`AccountsReceivableNetCurrent`	$152.38M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	235,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $5,128 in 2015 and $4,306 in 2014	`AccountsReceivableNetCurrent`	$188.32M	USD	Point-in-time
Inventories	`InventoryNet`	$160.34M	USD	Point-in-time
Inventories	`InventoryNet`	$188.83M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	54.57M	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	12.24M	shares	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$39.83M	USD	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$37.69M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.07M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$86.45M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$759.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$821.63M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$333.03M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$303.59M	USD	Point-in-time
Goodwill	`Goodwill`	$184.45M	USD	Point-in-time
Goodwill	`Goodwill`	$178.93M	USD	Point-in-time
Goodwill	`Goodwill`	$174.99M	USD	Point-in-time
Goodwill	`Goodwill`	$180.52M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$65.12M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.91M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$71.65M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$85.49M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$653.36M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$624.81M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.38B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.47B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.65M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$44.74M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$195.35M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$205.53M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$549.00M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$573.00M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$31.81M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$25.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$856.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$820.91M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$41.69M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$49.39M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$350.00M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$597.09M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$27.05M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$21.66M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$28.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$32.36M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$445.72M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$702.23M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.27B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.56B	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 102,237 and 101,947 shares in 2015 and 2014, respectively	`CommonStockValue`	$10.20M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 102,237 and 101,947 shares in 2015 and 2014, respectively	`CommonStockValue`	$10.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$888.29M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$940.53M	USD	Point-in-time
Deferred stock units: Outstanding: 240 and 235 units in 2015 and 2014, respectively	`CommonStockOtherValueOutstanding`	$5.41M	USD	Point-in-time
Deferred stock units: Outstanding: 240 and 235 units in 2015 and 2014, respectively	`CommonStockOtherValueOutstanding`	$5.07M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.68B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$318.36M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$13.62M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-42.27M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.07M	USD	Point-in-time
Treasury stock, at cost: 12,242 and 54,574 shares in 2015 and 2014, respectively	`TreasuryStockValue`	$2.45B	USD	Point-in-time
Treasury stock, at cost: 12,242 and 54,574 shares in 2015 and 2014, respectively	`TreasuryStockValue`	$1.32B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$-84.12M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$117.52M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$73.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$130.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$518.21M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$636.26M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.38B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.47B	USD	Point-in-time

Income Statement 115 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	$899.41M	USD	Annual
Product revenue	`SalesRevenueGoodsNet`	$974.93M	USD	Annual
Product revenue	`SalesRevenueGoodsNet`	$854.53M	USD	Annual
Service revenue	`SalesRevenueServicesNet`	$586.39M	USD	Annual
Service revenue	`SalesRevenueServicesNet`	$522.53M	USD	Annual
Service revenue	`SalesRevenueServicesNet`	$626.96M	USD	Annual
Total revenue	`SalesRevenueNet`	$1.60B	USD	Annual
Total revenue	`SalesRevenueNet`	$382.48M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$351.96M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$406.39M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.38B	USD	Annual
Total revenue	`SalesRevenueNet`	$360.20M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$390.12M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$413.34M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.49B	USD	Annual
Total revenue	`SalesRevenueNet`	$383.52M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$399.69M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$360.21M	USD	Annual
Cost of product revenue	`CostOfGoodsSold`	$335.05M	USD	Annual
Cost of product revenue	`CostOfGoodsSold`	$318.69M	USD	Annual
Cost of service revenue	`CostOfServices`	$351.41M	USD	Annual
Cost of service revenue	`CostOfServices`	$302.25M	USD	Annual
Cost of service revenue	`CostOfServices`	$334.64M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$711.62M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$669.69M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$620.94M	USD	Annual
Gross profit	`GrossProfit`	$218.52M	USD	1 Quarter
Gross profit	`GrossProfit`	$182.16M	USD	1 Quarter
Gross profit	`GrossProfit`	$213.34M	USD	1 Quarter
Gross profit	`GrossProfit`	$202.10M	USD	1 Quarter
Gross profit	`GrossProfit`	$890.27M	USD	Annual
Gross profit	`GrossProfit`	$215.54M	USD	1 Quarter
Gross profit	`GrossProfit`	$232.76M	USD	1 Quarter
Gross profit	`GrossProfit`	$816.12M	USD	Annual
Gross profit	`GrossProfit`	$756.12M	USD	Annual
Gross profit	`GrossProfit`	$217.69M	USD	1 Quarter
Gross profit	`GrossProfit`	$224.27M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$299.95M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$243.49M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$283.71M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$157.86M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$182.51M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$173.89M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$99.68M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$88.00M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$98.26M	USD	Annual
Impairment charge	`ImpairmentOfIntangibleAssetsFinitelived`	$8.21M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$72.80M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$260.25M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$83.22M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$66.91M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$88.30M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$266.76M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$70.05M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$71.89M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$34.80M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$72.19M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$299.91M	USD	Annual
Interest expense	`InterestExpense`	$5.39M	USD	Annual
Interest expense	`InterestExpense`	$15.43M	USD	Annual
Interest expense	`InterestExpense`	$29.24M	USD	Annual
Interest income	`InterestAndOtherIncome`	$1.89M	USD	Annual
Interest income	`InterestAndOtherIncome`	$2.47M	USD	Annual
Interest income	`InterestAndOtherIncome`	$1.73M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$273.14M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$263.26M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$246.56M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$75.47M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$81.01M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$64.60M	USD	Annual
Net income	`ProfitLoss`	$181.95M	USD	Annual
Net income	`ProfitLoss`	$187.79M	USD	Annual
Net income	`ProfitLoss`	$192.13M	USD	Annual
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-6.00K	USD	Annual
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$45.00K	USD	Annual
Less: Net income (loss) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$57.00K	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$25.96M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$44.22M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$56.91M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.59M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$52.14M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$44.35M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$181.91M	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$192.08M	USD	Annual
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$57.22M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$46.59M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$187.80M	USD	Annual
Basic	`EarningsPerShareBasic`	$0.61	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.77	USD	Annual
Basic	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.45	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.49	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.52	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.82	USD	Annual
Basic	`EarningsPerShareBasic`	$0.27	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.48	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$2.07	USD	Annual
Basic	`EarningsPerShareBasic`	$0.49	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.49	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.27	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.48	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.60	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.55	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.79	USD	Annual
Diluted	`EarningsPerShareDiluted`	$1.74	USD	Annual
Diluted	`EarningsPerShareDiluted`	$0.48	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.45	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.52	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$2.05	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.60M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	100.09M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	106.32M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	107.97M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.50M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.65M	shares	Annual

Cash Flow Statement 99 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$181.95M	USD	Annual
Net income	`ProfitLoss`	$187.79M	USD	Annual
Net income	`ProfitLoss`	$192.13M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$58.89M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$54.60M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$68.96M	USD	Annual
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$1.43M	USD	Annual
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$8.21M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$2.20M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$2.04M	USD	Annual
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$1.60M	USD	Annual
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$2.07M	USD	Annual
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$830.00K	USD	Annual
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$5.14M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$16.54M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$18.10M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$19.88M	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$614.00K	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$-472.00K	USD	Annual
Other	`OtherOperatingActivitiesCashFlowStatement`	$-160.00K	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$11.31M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$14.16M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$16.08M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.63M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$50.14M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$15.95M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$34.97M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.35M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$38.31M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$6.70M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-4.40M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-2.47M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-319.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$14.20M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$6.44M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-11.32M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-12.19M	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-18.09M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$216.36M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$246.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$235.85M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$77.61M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$60.52M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$82.92M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$271.96M	USD	Annual
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$56.77M	USD	Annual
Proceeds from disposition of pharmaceutical product lines	`ProceedsFromSaleOfOtherProductiveAssets`	$3.50M	USD	Annual
Proceeds from sale of equity investment	`EquityMethodInvestmentNetSalesProceeds`	$-5.40M	USD	Annual
Acquisitions of intangible assets	`PaymentsToAcquireIntangibleAssets`	$1.02M	USD	Annual
Acquisitions of intangible assets	`PaymentsToAcquireIntangibleAssets`	$175.00K	USD	Annual
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$25.11M	USD	Annual
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.30M	USD	Annual
Acquisitions of a businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.92M	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-86.06M	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-308.41M	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-80.41M	USD	Annual
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$65.00M	USD	Annual
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$272.00M	USD	Annual
Borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$24.00M	USD	Annual
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$250.10M	USD	Annual
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$200.00M	USD	Annual
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$150.00M	USD	Annual
Debt issue costs	`DebtIssuanceCosts`	$-976.00K	USD	Annual
Debt issue costs	`DebtIssuanceCosts`	$-1.41M	USD	Annual
Debt issue costs	`DebtIssuanceCosts`	$-1.38M	USD	Annual
Payment of notes payable	`RepaymentsOfSecuredDebt`	$1.39M	USD	Annual
Payment of notes payable	`RepaymentsOfSecuredDebt`	$1.11M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$401.98M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$618.16M	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$367.76M	USD	Annual
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$38.23M	USD	Annual
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$29.44M	USD	Annual
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$22.40M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$14.16M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$11.31M	USD	Annual
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$16.08M	USD	Annual
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-95.55M	USD	Annual
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-102.45M	USD	Annual
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-103.44M	USD	Annual
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.95M	USD	Annual
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-8.52M	USD	Annual
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.41M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$43.48M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$55.07M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-193.54M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$223.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$223.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$279.06M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$5.02M	USD	Annual
Interest paid	`InterestPaidNet`	$27.19M	USD	Annual
Interest paid	`InterestPaidNet`	$12.28M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$54.88M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$60.24M	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	$67.72M	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$518.21M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$636.26M	USD	Point-in-time
Balance, shares	`CommonStockSharesIssued`	102.24M	shares	Point-in-time
Balance, shares	`CommonStockSharesIssued`	101.95M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$181.95M	USD	Annual
Net income (loss)	`ProfitLoss`	$187.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$192.13M	USD	Annual
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-34.19M	USD	Annual
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-2.33M	USD	Annual
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-21.69M	USD	Annual
Repurchases of common stock	`StockholdersEquityOther`	$-623.89M	USD	Annual
Repurchases of common stock	`StockholdersEquityOther`	$-372.19M	USD	Annual
Repurchases of common stock	`StockholdersEquityOther`	$-412.17M	USD	Annual
Common stock issued under stock plans, including excess tax benefit, value	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$51.93M	USD	Annual
Common stock issued under stock plans, including excess tax benefit, value	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$32.76M	USD	Annual
Common stock issued under stock plans, including excess tax benefit, value	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$45.24M	USD	Annual
Deferred stock units activity	`IssuanceVestingAndSettlementOfDeferredStockUnits`	$-332.00K	USD	Annual
Deferred stock units activity	`IssuanceVestingAndSettlementOfDeferredStockUnits`	$189.00K	USD	Annual
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.10M	USD	Annual
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$16.57M	USD	Annual
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.88M	USD	Annual
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$117.59M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$518.21M	USD	Point-in-time
Balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$636.26M	USD	Point-in-time
Balance, shares	`CommonStockSharesIssued`	102.24M	shares	Point-in-time
Balance, shares	`CommonStockSharesIssued`	101.95M	shares	Point-in-time

Comprehensive Income 40 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$181.95M	USD	Annual
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-63.00K	USD	Annual
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$165.00K	USD	Annual
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-93.00K	USD	Annual
Net income	`ProfitLoss`	$187.79M	USD	Annual
Net income	`ProfitLoss`	$192.13M	USD	Annual
Unrealized gain, tax expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$1.55M	USD	Annual
Unrealized gain, tax expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$3.74M	USD	Annual
Unrealized gain, tax expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$4.07M	USD	Annual
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$756.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.50M	USD	Annual
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$5.85M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.72M	USD	Annual
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$679.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-29.13M	USD	Annual
Unrealized gain on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$1.89M	USD	Annual
Unrealized gain (loss) on investments, net of tax expense (benefit) of ($93), ($63) and $165 in 2015, 2014, and 2013, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$279.00K	USD	Annual
Unrealized gain (loss) on investments, net of tax expense (benefit) of ($93), ($63) and $165 in 2015, 2014, and 2013, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-107.00K	USD	Annual
Unrealized gain (loss) on investments, net of tax expense (benefit) of ($93), ($63) and $165 in 2015, 2014, and 2013, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-226.00K	USD	Annual
Unrealized gain, net of tax expense of $3,736, $4,073 and $1,555 in 2015, 2014 and 2013, respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$3.78M	USD	Annual
Unrealized gain, net of tax expense of $3,736, $4,073 and $1,555 in 2015, 2014 and 2013, respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$8.84M	USD	Annual
Unrealized gain, net of tax expense of $3,736, $4,073 and $1,555 in 2015, 2014 and 2013, respectively	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$9.54M	USD	Annual
Less: reclassification adjustment for gains included in net income, net of tax expense of $5,853, $756 and $679 in 2015, 2014 and 2013, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$2.00M	USD	Annual
Less: reclassification adjustment for gains included in net income, net of tax expense of $5,853, $756 and $679 in 2015, 2014 and 2013, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$1.89M	USD	Annual
Less: reclassification adjustment for gains included in net income, net of tax expense of $5,853, $756 and $679 in 2015, 2014 and 2013, respectively	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$13.98M	USD	Annual
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$1.89M	USD	Annual
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$7.54M	USD	Annual
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-5.14M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-34.19M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.33M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-21.69M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$157.94M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$160.26M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$185.46M	USD	Annual
Less: comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$45.00K	USD	Annual
Less: comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-6.00K	USD	Annual
Less: comprehensive income (loss) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$57.00K	USD	Annual
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$185.47M	USD	Annual
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$160.21M	USD	Annual
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$157.88M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.